Clinical Trial: An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Nonalcoholic Fatty Liver Disease
Study Type: INTERVENTIONAL
Official Title: Effects of Compound Silymarin on Biomarkers of Lipid Metabolism and Inflammation in Patients With Non-alcoholic Fatty Liver Disease: A Randomized Controlled Double-blind Trial
Brief Summary:
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China.The aim of this project is to evaluate the effects of compound silymarin on biomarkers of lipid metabolism and inflammation in the patients with NAFLD.
Read more